Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
1999
New Breast Cancer Cell Line KPL-4 and Its Characteristics
publication
Evidence: moderate
Author Information
Author(s): Kurebayashi J, Otsuki T, Kurosumi M, Yamamoto S, Tanaka K, Mochizuki M, Nakamura H
Primary Institution: Kawasaki Medical School
Hypothesis
Can the new KPL-4 breast cancer cell line provide insights into breast cancer treatment strategies?
Conclusion
The KPL-4 cell line may help develop new strategies against breast cancer that overexpresses Erb B family receptors and IL-6-induced cachexia.
Supporting Evidence
- KPL-4 cells can be cultured under serum-free conditions.
- KPL-4 cells are tumorigenic in female athymic nude mice.
- The cell line expresses Erb B-1, -2, and -3 receptors.
- A 15-fold amplification of erbB-2 was observed.
- High levels of interleukin-6 were detected in culture medium and mouse serum.
- The weight of tumors correlated with serum IL-6 levels.
- The anti-Erb B-2 monoclonal antibody significantly inhibited KPL-4 cell growth in vitro.
Takeaway
Scientists created a new type of breast cancer cell that can grow without special conditions and makes mice lose weight. This could help find better treatments for breast cancer.
Methodology
The KPL-4 cell line was isolated from a breast cancer patient and analyzed for receptor expression and tumorigenicity in mice.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website